v3.26.1
Commitments and Contingencies - Collaboration Agreements (FY) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 29, 2020
Mar. 31, 2026
Dec. 31, 2025
Commitments and Contingencies      
Non - Refundable aggregate fees payable   $ 1,000 $ 1,000
Non - Refundable upfront fees payable   500 500
Non - Refundable fees payable   500 500
Divestiture fee due to Catalent   924 924
Amount of loss contingency   $ 0 $ 0
Common stock 150,000    
Loss contingency, shares agreed by defendant 33,836 1,692 1,692
Target annual bonus   150.00% 150.00%
Amended and restated agreement      
Commitments and Contingencies      
Amount payable per product candidate for rare, monogenic disorders   $ 16,500 $ 16,500
Sales milestone payments   55,000 55,000
Gemma License Agreement      
Commitments and Contingencies      
Amount payable per product candidate for rare, monogenic disorders   16,500 16,500
Amount payable per product candidate upon achievement of specific development milestone   39,000 39,000
Sales milestone payments   $ 55,000 $ 55,000